Home › Trial NCT07236112
Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer
- Trial IDNCT07236112
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorC Ray Therapeutics
- Enrollment6
- Start date2026-02-08
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.